 |
 |
|
|
|
Nabio GH |
 |
Galanthamine Hydrobromide |
 |
Galanthamine Hydrobromide is adopted as the component of some medicines for the treatment of mild to moderate dementia of the Alzheimer's type in clinic. |
 |
inhibiting of cholinesterase, increasing the susceptibility of the organism to acetylcholine. |
Industrial field |
pharmaceutical |
|
|
 |
|
|
|
 |
There are no existing companies to distribute selected chemical product |
|
 |
|
|
|